The ACR Research and Education Foundation (REF) maintains an extensive award and grant program with research, training, and education opportunities for medical students, fellows, clinicians, researchers, health professionals, and academic institutions. This month, the REF continues to recognize its latest group of award recipients, who will begin their award terms in July.
Medicare Switch to ASP Pricing Reduces Part B Spending
The Medicare Payment Advisory Commission (MedPAC) reported to Congress in January that Medicare’s switch to a payment method known as ASP, or Average Sale Price, has reduced spending on drugs in the Medicare Part B program. This system reflects actual market spending, rather than wholesale prices.
Rheum’s Role in the New National Health Service
What the United States can learn from the U.K. system
Reading Rheum
Handpicked Reviews of Contemporary Literature
2007–2008 REF Award Recipients
The REF ensures the future of rheumatology by ensuring that there are well-trained rheumatologists and rheumatology health professionals to provide quality care. To achieve this, REF maintains an extensive award and grant program with research, training, and education opportunities for medical students, fellows, clinicians, researchers, health professionals, and academic institutions.
ACR REF Launches ‘Within Our Reach’
The ACR Research and Education Foundation (REF) has launched “Within Our Reach,” a national, multiyear, $30-million fundraising campaign aimed at accelerating innovative research on rheumatoid arthritis. RA—long considered one of the most disabling types of arthritis—has been a primary focus of rheumatologic research. Recent advances in the basic management of RA include targeted treatments and improvements in treating other types of inflammatory arthritis. Unfortunately, we still do not know the cause of RA or have a cure.
ACR State-of-the-Art Clinical Symposium
Join the ACR in Chicago April 13–15 for the 2007 State-of-the-Art Clinical Symposium. The symposium will start with a focus on lupus with presentations on pathophysiology, trial metrics, and a review of recently completed clinical trials. Saturday afternoon will include an update on several diseases including Sjögren’s syndrome, fibromyalgia, pediatric vasculitis, and myositis. Following RA presentations Sunday morning, the symposium will conclude with the always-popular “Year in Review” presentation.
Keep ACR at the Table
Without your help, ACR will lose its clout at the AMA
Your Representatives on Capitol Hill
Government Affairs Committee advocates on behalf of the ACR and all rheumatologists
Science from our Sisters
Recommended reading from A&R and AC&R